Study of Bariatric Surgery (BARIASURG)

August 2, 2016 updated by: Hospices Civils de Lyon

Prospective Cohort Study Monitoring Patients Undergoing Bariatric Surgery

The aim of this cohort study is to collect prospectively clinical data on all the patients admitted in the investigators department for bariatric surgery or for any complication of a bariatric procedure. The investigators goal is not only to improve the follow-up but also to assess and publish the investigators results regarding weight loss and the complication rate.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

5000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • France
      • Lyon, France, 69003
        • Recruiting
        • Department of Digestive Surgery, University Hospital of Edouard Herriot, Hospices Civils de Lyon
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 80 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Obese patients (BMI > 30) or patients admitted for a bariatric surgery complication

Description

Inclusion Criteria:

  • History of bariatric surgery procedure

Exclusion Criteria:

  • Patients < 16 years
  • Patients > 80 years

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Weight loss in kg
Time Frame: Before surgery (Day 0) and After surgery (every year, up to 25 years or loss to follow-up)
Before surgery (Day 0) and After surgery (every year, up to 25 years or loss to follow-up)
Weight loss in kg/m²
Time Frame: Before surgery (Day 0) and After surgery (every year, up to 25 years or loss to follow-up)
Before surgery (Day 0) and After surgery (every year, up to 25 years or loss to follow-up)
Excess Weight Loss
Time Frame: Before surgery (Day 0) and After surgery (every year, up to 25 years or loss to follow-up)
Before surgery (Day 0) and After surgery (every year, up to 25 years or loss to follow-up)
% weight loss
Time Frame: Before surgery (Day 0) and After surgery (every year, up to 25 years or loss to follow-up)
Before surgery (Day 0) and After surgery (every year, up to 25 years or loss to follow-up)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
type of surgical procedure
Time Frame: at the time of surgery (Day 1)
gastric bypass, sleeve gastrectomy, gastric banding, biliopancreatic diversion, redo surgery, endoscopic procedure…
at the time of surgery (Day 1)
age
Time Frame: before surgery (Day 0)
demographic data: age
before surgery (Day 0)
gender
Time Frame: before surgery (Day 0)
demographic data: gender
before surgery (Day 0)
Type of comorbidities
Time Frame: before surgery (Day 0)
demographic data: comorbidities (diabetes, arterial hypertension, sleep apnea, dyslipidemia)
before surgery (Day 0)
surgical complications
Time Frame: per and postoperative (up to 25 years or loss to follow-up)
leaks, hemorrhage, phlebitis, pulmonary embolism, nutritional deficiencies, occlusions,…
per and postoperative (up to 25 years or loss to follow-up)
dose of insulin
Time Frame: after surgery (up to 25 years or loss to follow-up)
evolution of comorbidities: evolution of medical treatment
after surgery (up to 25 years or loss to follow-up)
number of oral medications
Time Frame: after surgery (up to 25 years or loss to follow-up)
evolution of comorbidities: evolution of medical treatment
after surgery (up to 25 years or loss to follow-up)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hospices Civils de Lyon

Investigators

  • Principal Investigator: Maud ROBERT, Pr, Department of Digestive Surgery, University Hospital of Edouard Herriot, Hospices Civils de Lyon

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2007

Primary Completion (Anticipated)

November 1, 2032

Study Completion (Anticipated)

November 1, 2032

Study Registration Dates

First Submitted

July 27, 2016

First Submitted That Met QC Criteria

August 2, 2016

First Posted (Estimate)

August 5, 2016

Study Record Updates

Last Update Posted (Estimate)

August 5, 2016

Last Update Submitted That Met QC Criteria

August 2, 2016

Last Verified

July 1, 2016

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 69HCL16_0504

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bariatric Surgery

Clinical Trials on bariatric surgery

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Armenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe